Teva Pharmaceutical Industries Ltd. ADR-0.06% $20.31B ...

Women in England with a specific type of endometrial cancer will be able to access an immunotherapy for the first time, after NICE backed use of GlaxoSmithKline's PD-1 inhibitor Jemperli via the ...

After hours: October 18 at 7:42 PM EDT Loading Chart for GSK ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

After hours: October 18 at 7:42 PM EDT ...

The ad says this wagon was factory spec’d with a 390, a C6, and a 9-inch rear end.

FDA accepted GSK's gepotidacin application for uUTI treatment with a PDUFA date set for March 26, 2025. Gepotidacin showed superior efficacy over nitrofurantoin in EAGLE-3 trial with a 58.5% ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Aditya Birla SL ELSS Tax Saver Fund (IDCW) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund (G) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund ...